Learn more about the 2017 plenary presenters and read their biographies below. Brief outlines of the speakers talks can be found here.
Sarcopenia and cachexia in chronic illness – definition, common pathophysiology and lessons learned from recent trials
Osteoporosis Treatment: Current Advances and Future Prospects
Lipodystrophy syndrome: history, where we are now, what have we learnt and the future
Cardiovascular Outcome Trials in T2DM
Brown fat and making white fat beige
Stefan D. Anker is Professor of Innovative Clinical Trials at University Medical Center Göttingen.
He obtained his MD from Charité Medical School, Berlin, Germany and a PhD at the National Heart and Lung Institute of Imperial College London. Dr. Anker’s research focuses on mechanisms for and treatment of cachexia and sarcopenia in patients with heart failure and cancer and in clinical trial design for interventions in these areas. He has authored more than 700 original papers, reviews, and editorials. He is Vice President of the European Society of Cardiology and serves on the board of the Heart Failure Association of the society. Dr. Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders and is the founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and Muscle. He was and is member of more than 25 international clinical trial steering committees, chairing or co-chairing several and has served on a number of Data Monitoring and End-Point Committees, chairing several.
Juliet Compston is Emeritus Professor of Bone Medicine at the University of Cambridge School of Clinical Medicine. Her research is focused on the pathophysiology of osteoporosis and the mechanisms by which pharmacological interventions reduce fracture risk. Recently her research has focused on fractures in obese postmenopausal women.
Professor Compston is Editor-in-Chief of the Journal of Bone and Mineral Research. She is Chair of the European Union Osteoporosis Consultation Panel and of the UK National Osteoporosis Guidelines Group. She has published over 350 original research papers and reviews.
In 2006, Professor Compston was awarded the National Osteoporosis Society Kohn Foundation Award, and in 2009, the International Bone and Mineral Society John G Haddad Jr Award and the ASBMR Frederic C Bartter Award. In 2014 she was appointed an Officer of the Order of the British Empire for services to the treatment of osteoporosis.
Biography to follow
Professor Stefano Del Prato is Professor of Endocrinology and Metabolism at the School of Medicine, University of Pisa and Chief of the Section of Diabetes, University of Pisa, Italy. He graduated MD cum laude from the University of Padova and undertook postgraduate specialization in both Endocrinology and Internal Medicine. Professor Del Prato’s research interests have always been concerned with diabetes and, in particular, the physiopathology and therapy of type 2 diabetes and insulin resistance syndrome.
He is a member of many societies and associations including the European Association for the Study of Diabetes, the American Diabetes Association, and the International Diabetes Federation. He acts as referee for numerous major journals. Furthermore, Professor Del Prato currently serves on the Editorial Boards for Diabetes Care, and he is Associate Editor of the Journal of Endocrinological Investigation and the Journal of Diabetes and Its Complications and Assistant Editor of Diabetes & Vascular Disease Research.
Professor Del Prato is past Vice President of the EASD, past President of the Italian Society of Diabetology, and the current Chairman of the Scientific Committee of the European Foundation for the Study of Diabetes. He also served as Chairman of the Scientific Committee of the World Diabetes Congress in Dubai, UAE, in 2011. He has published over 450 articles in peer-reviewed international journals and has been awarded several honors, including the Prize of the Italian Society of Diabetology for outstanding scientific activity and the Honorary Professorship at the Universidad Peruana Cayetano Heredya in Lima, Peru.
Sven Enerbäck received his MD 1984 and PhD 1992 from University of Gothenburg, Sweden, in 1993 he received his license to practice medicine. For postdoctoral training Dr Enerbäck joined the laboratory of Leslie P. Kozak during 1993-94, at The Jackson Laboratory in Bar Harbor, Maine. He was appointed full professor of Medical Genetics at the Medical faculty of University of Gothenburg in 2000. His research focuses on metabolism particularly on white and brown adipose tissue and its role in systemic energy turn-over. He was a Pfizer visiting professor at University of Michigan 2004 and was awarded The Söderberg Foundation Chair in Medicine 2009. In 2010 Dr Enebäck was awarded The Anniversary Medical Prize of The Swedish Medical Society. He is an elected member of The Royal Society of Arts and Sciences since and the medical class of The Swedish Royal Academy of Science.